Precisely Tuned Inhibition of HIF Prolyl Hydroxylases Is Key for Cardioprotection After Ischemia

Circ Res. 2021 Apr 16;128(8):1208-1210. doi: 10.1161/CIRCRESAHA.120.318216. Epub 2021 Feb 25.

¹ Institute of Cardiovascular Physiology, University Medical Center Göttingen, Göttingen, Germany (A.J., A.Z., K.B.-C., A.M.V., D.M.K.).
² Nuffield Department of Medicine Research Building, Old Road Campus, Oxford (A.Y., M.L.C., C.W.P., P.J.R.).
³ Now with Institute of Cancer and Genomic Sciences, University of Birmingham (M.L.C.).
⁴ Henry Wellcome Building for Genomic Medicine, Old Road Campus, Oxford, OX3 7BN, United Kingdom (D.B., B.D.).
⁵ The Francis Crick Institute, 1 Midland Road, London NW1 1AT, United Kingdom (P.J.R.).
⁶ German Center for Cardiovascular Research (DZHK), Partner site Göttingen, Germany (D.M.K.).

No abstract available

Keywords: doxycycline; heart failure; incidence; myocardial infarction; prolyl hydroxylase.

Publication types